Novo Nordisk A/S (NONOF)
57.20
-0.58 (-1.00%)
At close: Apr 21, 2025, 3:55 PM
-1.00% (1D)
| Bid | 56.5 |
| Market Cap | 253.91B |
| Revenue (ttm) | 290.4B |
| Net Income (ttm) | 100.99B |
| EPS (ttm) | 3.42 |
| PE Ratio (ttm) | 16.73 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 60 |
| Volume | 900 |
| Avg. Volume (20D) | 117,122 |
| Open | 57.42 |
| Previous Close | 57.78 |
| Day's Range | 57.00 - 61.44 |
| 52-Week Range | 57.20 - 149.55 |
| Beta | 0.25 |
About NONOF
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ...
Industry Biotechnology
Sector Healthcare
IPO Date May 7, 2010
Employees 76,302
Stock Exchange PNK
Ticker Symbol NONOF
Website https://www.novonordisk.com